Skip to main content
. 2021 May 25;11:e2021288. doi: 10.4322/acr.2021.288

Table 2. Main differential diagnoses of EIMS.

Tumor Immunohistochemistry
EIMS ALK +, SMA +, EMA +/-, CK +/-, CD30 +, CD34 -, and Desmin +
GIST CD117 +, DOG1 +, CD34 +, and Desmin -
ALCL ALK +, SMA +, EMA +, CD30 +, and Desmin -
ELMS ALK -, SMA +, EMA + and Desmin +
LGFMS EMA +, MUC4 +, CD99, BCL2, SMA +/-, and Desmin +/-
RMS ALK+/-, Myogenin +, MyoD1 +, Desmin +, SMA +, EMA -, CD30 -
MM CK5 +, Calretinin +, EMA +/-, and Desmin -
Our case ALK +, SMA +, CD30 +, CK-, EMA -, CD34 -, and Desmin +

ALCL, anaplastic large cell lymphoma; ALK, anaplastic lymphoma kinase ; BCL, B cell lymphoma; CD, cluster of differentiation; CK, cytokeratin; DOG1, discovered on GIST 1 ; EIMS, epithelioid inflammatory myofibroblastic sarcoma; EMA, epithelial membrane antigen; ELMS, epithelioid leiomyosarcoma, ; GIST, gastrointestinal stromal tumor; LGFMS, low grade fibromyxoid sarcoma; MM, malignant mesothelioma; MUC, mucin; MyoD1, myoblast determination protein 1; RMS, rhabdomyosarcoma; SMA, smooth muscle actin.